Ultragenyx Pharmaceutical Inc.·4

Apr 20, 5:15 PM ET

Parschauer Karah Herdman 4

4 · Ultragenyx Pharmaceutical Inc. · Filed Apr 20, 2026

Research Summary

AI-generated summary of this filing

Updated

Ultragenyx (RARE) EVP Karah Parschauer Receives RSU Award

What Happened Karah Parschauer, Executive Vice President and Chief Legal Officer of Ultragenyx Pharmaceutical Inc. (RARE), received two restricted stock unit (RSU) awards on 2026-04-16 totaling 78,855 RSUs (28,895 RSUs + 49,960 RSUs). Both awards are reported as acquisitions at $0.00 (standard for equity awards); no cash was paid. This is an equity grant (award), not a market purchase or sale.

Key Details

  • Transaction date: 2026-04-16; filing date: 2026-04-20 (filing appears timely).
  • Reported amounts: 28,895 RSUs (A) and 49,960 RSUs (A, listed as a derivative).
  • Reported price: $0.00 per RSU (award/grant).
  • Vesting: RSUs vest 1/4th on each anniversary of the grant and fully vest on the fourth anniversary (per footnote F1).
  • Footnotes: F2 notes the reported amounts include previously reported shares underlying RSUs subject to vesting; F3 describes a separate option vesting schedule (monthly after the first anniversary) though no option exercise is reported here.
  • Shares owned after the transaction: not specified in the provided filing excerpt.

Context

  • These are time-based RSU awards that convert into company shares only as they vest; the derivative listing simply reflects rights to future shares rather than immediate share ownership. Such grants are common compensation for executives and are neither an open-market purchase (a potential bullish signal) nor a sale.

Insider Transaction Report

Form 4
Period: 2026-04-16
Parschauer Karah Herdman
EVP and Chief Legal Officer
Transactions
  • Award

    Common Stock

    [F1][F2]
    2026-04-16+28,89595,715 total
  • Award

    Stock Option (Right to Buy)

    [F3]
    2026-04-16+49,96049,960 total
    Exercise: $24.52Exp: 2036-04-16Common Stock (49,960 underlying)
Footnotes (3)
  • [F1]Award of Restricted Stock Units ("RSUs") under the Company's 2023 Incentive Plan. The RSUs shall vest with respect to 1/4th of the underlying shares on each anniversary of the grant date, such that the RSUs are fully vested on the fourth anniversary of the grant date
  • [F2]Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions.
  • [F3]On the first anniversary of the grant date of the option (the "Option Anniversary Date"), 1/4th of the shares initially subject to the option shall vest; thereafter, 1/48th of the shares initially subject to the option shall vest on each month as measured from the Option Anniversary Date.
Signature
/s/ Karah Parschauer|2026-04-20

Documents

1 file
  • 4
    ownership.xmlPrimary

    4